123 results
Page 5 of 7
6-K
EX-4.1
f3pn8jot
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
ol7v5up
12 May 20
Current report (foreign)
12:04pm
424B5
3t58w5
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-4.1
h9cmh0a1hsa
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-10.1
hsvq5fiek1tx3e
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
5d3obhxhk vw
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
1xaw8sxk59h 5v1
14 Nov 19
Current report (foreign)
7:01am
6-K/A
542eaq
29 Aug 19
Current report (foreign) (amended)
5:25pm
6-K
1qw848sy
13 Aug 19
Current report (foreign)
7:00am
S-8
EX-5.1
5xp4bk
27 Jun 19
Registration of securities for employees
4:06pm
6-K
EX-10.1
4k2g9wb
17 May 19
Current report (foreign)
5:20pm
424B5
spj16 wmkntwlpugvqmr
17 May 19
Prospectus supplement for primary offering
5:19pm
6-K
bxk4pi5s
15 May 19
Current report (foreign)
7:00am
6-K
bcoqn
20 Nov 18
Current report (foreign)
7:00am
6-K
kdvrd 4q2lmamurwe
16 Aug 18
Current report (foreign)
7:00am
424B5
pr1391ffno5mb46
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-4.1
vbxylpa5
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-1.1
ka86wu430dxt
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am